MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Postural Stability in Blepharospasm and the Effects of Botulinum Toxin Therapy

    M. Balal, T. Demir, M. Erdem, M. Demirkiran (Adana, Turkey)

    Objective: To determine (1) how blepharospasm effects postural stability and (2) to evaluate the efficacy of botulinum toxin therapy (BoNT-A) on static balance in patients…
  • 2018 International Congress

    Assessment of cognitive functions, depression-anxiety scales and quality of life in patients and their relatives with Cervical Dystonia and Botulinum Toxin Treatment

    D. Ceylan, S. Erer, M. Zarifoglu, N. Turkes, A. Demiralay (Bursa, Turkey)

    Objective: In this study, we investigated the psychiatric comorbid disorders and quality of life issues such as cognitive dysfunction accompanied by cervical dystonia and accompanying…
  • 2018 International Congress

    The phenotype of ATP1A3+ Rapid-Onset Dystonia-Parkinsonism (RDP) is broader than previously defined

    I. Haq, B. Snively, C. Suerken, J. Cook, C. Miller, K. Sweadner, L. Ozelius, C. Whitlow, A. Brashear (Winston Salem, NC, USA)

    Objective: To update the phenotype of RDP based on a cohort of ATP1A3 mutation+ individuals. Background: RDP is caused by mutations of the ATP1A3 gene,…
  • 2018 International Congress

    Mingo Supplement Trial: An Open-Labeled Randomized-Controlled Trial in X-linked Dystonia-Parkinsonism patients in the Province of Capiz, Philippines

    P. Acuna, G. Solinap, M. Ang, J. de Guzman, C. Go (Charlestown, MA, USA)

    Objective: To see whether increasing the caloric intake of patients by 480 calories per day using a locally sourced food supplement, Mingo, would raise the…
  • 2018 International Congress

    Impaired reaching movements in idiopathic cervical dystonia patients

    A. Castagna, L. Sciumè, A. Caronni, D. Anastasi, A. Montesano, A. Marzegan (Milano, Italy)

    Objective: Aim of the current study is to describe how patients with idiopathic cervical dystonia (CD) perform reaching movements with their upper limb (i.e. a…
  • 2018 International Congress

    Does having more children really delay Parkinson’s age of onset in women?

    M. MacAskill, D. Myall, T. Pitcher, T. Melzer, J. Dalrymple-Alford, T. Anderson (Christchurch, New Zealand)

    Objective: Childbirth has been proposed to be protective of Parkinson’s (PD), in that having a higher number of children is associated with a later age…
  • 2018 International Congress

    Prevalence and influence of co-pathologies in patients with autopsy-confirmed Lewy body disorders: A systematic review

    D. Breen, E. Ravid, A. Lang, J. Miyasaki, R. Camicioli (Toronto, ON, Canada)

    Objective: To determine the prevalence of selected co-pathologies in patients with Lewy Body disorders, as well as their influence on disease expression. Background: The presence…
  • 2018 International Congress

    Clinical and genetic data of Huntington disease in Uzbekistan patient

    M. Rakhimova (Tashkent, Uzbekistan)

    Objective: Huntington's disease (HD) occurs worldwide with prevalence varying from 0.1 to 10/100,000 depending of the ethnic origin. Since no data is available in the…
  • 2018 International Congress

    Malignant gliomas in patients with Huntington’s disease

    S. Chandra, G. Suarez-Cedeno, E. Stimming (Houston, TX, USA)

    Objective: Discuss the presentation of glioblastoma multiforme in patients with Huntington’s disease Background: Huntington’s disease (HD) is an inherited neurodegenerative disorder caused by a trinucleotide…
  • 2018 International Congress

    REM sleep-related episodes in children with Narcolepsy type 1 after treatment with Sodium Oxybate

    E. Antelmi, F. Pizza, G. Plazzi (Bologna, Italy)

    Objective: We aimed to analyze the effect of Sodium Oxybate (SO) on motor events occurring during nighttime in children affected with Narcolepsy type 1 (NT1).…
  • « Previous Page
  • 1
  • …
  • 154
  • 155
  • 156
  • 157
  • 158
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley